CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 15 No. 9
Pages: 1  2  3  
Next
The Sawaya Article Reviewed 

Considerations in the Diagnosis and Management of Brain Metastases

By Fred G. Barker II, MD
Neurosurgeon, Brain Tumor Center, Neurosurgical Service, Massachusetts General Hospital, Boston, Massachusetts

| September 1, 2001

Dr. Sawaya’s review provides a comprehensive overview and excellent summary of current knowledge on an important topic. Brain metastases far outnumber primary brain tumors; their diagnosis and treatment are bread-and-butter for both medical and neurosurgical oncologists. Additionally, unlike primary brain tumors, a definable at-risk population exists for brain metastases, making prevention a potentially achievable goal.

Diagnosis

As Dr. Sawaya points out, however, many brain metastases are asymptomatic. Diagnosis and treatment before symptoms develop are important. When brain imaging is included in a "staging" work-up, magnetic resonance imaging (MRI) with and without gadolinium should be used rather than computed tomography (CT) because of its greater sensitivity. Most asymptomatic metastases are less than 1 cm in diameter, and many are only a few millimeters in size. Although MRI with "triple-dose" gadolinium is considered by some to be even more sensitive than standard contrast imaging, we have used standard contrast MRI with careful attention to the imaging sequences that highlight edema around small metastases. The fluid-attenuated inversion recovery (FLAIR) sequence is probably best for this purpose.

When a metastasis has a ring-enhancing appearance with surrounding edema, brain abscess is an important differential consideration. The characteristic bright appearance of abscesses on diffusion-weighted imaging is helpful in this regard, because the necrotic centers of most ring-enhancing metastases will show low or intermediate signal intensity.

We find that most brain metastases can be confidently diagnosed without obtaining tissue. In some situations, such as a single brain lesion with no known systemic cancer or with a chest primary of unknown histology that cannot be biopsied without thoracotomy, biopsy of a brain metastasis is necessary for diagnosis. Interstitial brachytherapy can be performed at the same sitting in this situation, using a probe introduced stereotactically into the center of the tumor to deliver in a few minutes a therapeutic single-fraction treatment equivalent to radiosurgery.[1]

Medical Treatment

As Dr. Sawaya notes, corticosteroids are indicated for most patients with brain metastases, especially those with neurologic symptoms. An exception occurs when brain lymphoma is a diagnostic consideration, because even a brief course of steroid treatment can cause complete regression of these lesions, thus thwarting biopsy.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy